🧪 Aurobindo Pharma Strengthens Growth with US Market Recovery & New Launches

Aurobindo Pharma is seeing improved momentum driven by recovery in the US generics market and new product launches. The company is benefiting from strong pipeline, regulatory approvals, and expansion in specialty and complex generics, supporting revenue growth. Cost optimisation and better product mix are aiding margins. Management remains optimistic, backed by global demand, product pipeline strength, and operational efficiency. 📌 StockYard Take: US recovery and pipeline expansion position Aurobindo Pharma for steady growth ahead. #AurobindoPharma #PharmaStocks #USMarket #Generics #StockYardResearch